KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Inventory (2016 - 2025)

Historic Inventory for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $6.7 billion.

  • Abbott Laboratories' Inventory fell 154.12% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year decrease of 154.12%. This contributed to the annual value of $6.2 billion for FY2024, which is 572.3% down from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Inventory is $6.7 billion, which was down 154.12% from $7.0 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Inventory ranged from a high of $7.0 billion in Q2 2025 and a low of $5.2 billion during Q4 2021
  • In the last 5 years, Abbott Laboratories' Inventory had a median value of $6.6 billion in 2023 and averaged $6.2 billion.
  • In the last 5 years, Abbott Laboratories' Inventory skyrocketed by 1970.14% in 2022 and then crashed by 572.3% in 2024.
  • Over the past 5 years, Abbott Laboratories' Inventory (Quarter) stood at $5.2 billion in 2021, then increased by 19.7% to $6.2 billion in 2022, then grew by 6.43% to $6.6 billion in 2023, then decreased by 5.72% to $6.2 billion in 2024, then grew by 8.3% to $6.7 billion in 2025.
  • Its Inventory was $6.7 billion in Q3 2025, compared to $7.0 billion in Q2 2025 and $6.6 billion in Q1 2025.